Please provide your email address to receive an email when new articles are posted on . Risk factors for patients with acute MI have changed modestly as treatment has improved, with mortality rates ...
Please provide your email address to receive an email when new articles are posted on . Risk for subsequent HF or death in the 5 years after STEMI or non-STEMI remains higher in women, compared with ...
Are there differences in outcome following PCI between patients with STEMI and those with non-STEMI?
Primary percutaneous coronary intervention (PCI) improves outcome in patients presenting with acute ST-segment elevation myocardial infarction (STEMI). Most trials, however, have excluded patients ...
SAN FRANCISCO -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, there was no clinical benefit to a strategy of finding and treating all nonculprit ...
Noninferiority was not demonstrated between immediate and staged complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease undergoing ...
PHILADELPHIA — Patients who survived an out-of-hospital cardiac arrest and did not have signs of ST-elevation myocardial infarction (STEMI) had similar 1-year survival whether they had immediate or ...
The benefits of complete revascularization over culprit-only coronary artery revascularisation were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel ...
For STEMI patients undergoing primary PCI, there are no significant differences in the risks of death, MI, or stroke between those treated with prasugrel and those who received ticagrelor, nor are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results